Volteface is accepting pitches for our website on this recent psilocybin study and what it means for psychedelic therapy. No particular deadline but the sooner the better – we’re always looking to commission pieces.
ABOUT THE COMPANY
Volteface is an independent research and advocacy organisation that seeks to reduce the harm drugs pose to individuals and society, through evidence-based policy reform. It cultivates fresh thinking and new ideas through our policy reports and online magazine.
WHAT TO INCLUDE IN SUBMISSION
More information: Interesting evidence on the use of psilocybin-assisted treatment: https://pubmed.ncbi.nlm.nih.
COMPENSATION
CONTACT
For more information, visit their visit.
Please email all questions and submissions to Katya Kowalski, Head of Operations at Volteface at katya@volteface.me.
Reuters is seeking an energetic and experienced journalist to join our team in Buenos Aires…
Digiday senior reporter Alexander Lee is now covering media and entertainment. He will continue to report on…
Bloomberg News is looking for an editor to join the Americas economic data news team…
The Wall Street Journal has hired Meridith McGraw to cover the White House. McGraw is a…
Dean Starkman writes for Columbia Journalism Review about how economics reporters need to do a better…
The Wall Street Journal has hired Gavin Bade to cover President Trump and trade. His first day…